BPG is committed to discovery and dissemination of knowledge
Case Report
Copyright: ©Author(s) 2026.
World J Gastrointest Surg. Jun 27, 2026; 18(6): 119246
Published online Jun 27, 2026. doi: 10.4240/wjgs.119246
Figure 1
Figure 1 Preoperative computed tomography findings of the pancreatic schwannoma. A: Plain computed tomography (CT) scan showing a well-marginated, slightly hypodense mass (arrow) in the pancreatic tail; B: Contrast-enhanced CT scans in the arterial phase demonstrating inhomogeneous mild enhancement of the lesion; C: Contrast-enhanced CT scans in the arterial phase demonstrating inhomogeneous mild enhancement of the lesion; D: Contrast-enhanced CT scan in the parenchymal phase showing progressive enhancement of the mass.
Figure 2
Figure 2 Preoperative magnetic resonance imaging findings of the pancreatic schwannoma. A: T1-weighted image showing a hypointense mass (arrow) in the pancreatic tail; B: T2-weighted image showing a slightly hyperintense mass; C: Diffusion-weighted imaging showing increased signal intensity of the lesion; D: T1 fat saturation postcontrast image showing mild enhancement of the mass after gadolinium administration.
Figure 3
Figure 3 Histopathological and immunohistochemical features of the pancreatic schwannoma. A: Hematoxylin and eosin staining (× 200) showing tumor cells arranged in palisades and whorls, with spindle-shaped nuclei, fine chromatin, and absence of mitosis; B: Immunohistochemical staining (× 100) showing negative expression of smooth muscle actin; C: Immunohistochemical staining (× 100) showing diffuse strong positivity for S-100 protein.


Write to the Help Desk